Home Authors Posts by Winway Health Desk

Winway Health Desk

3221 POSTS 0 COMMENTS

Shaping the EU’s ethics guidelines for trustworthy AI – the healthcare...

After releasing its AI Ethics Guidelines draft paper last year, the European Commission's AI high-level expert group (AI HLEG) ran an online stakeholder consultation to generate discussion and...

Fizz Free February campaign launches to tackle sugar consumption

A campaign called Fizz Free February is encouraging people to cut out sugary drinks for the rest of the month. The idea...

Does Bristol-Myers Squibb’s new activist investor want to stall its Celgene...

Analysts and investors have both expressed concerns over Bristol-Myers Squibb’s $74 billion Celgene deal agreement. And an activist may be joining that list. Known agitator...

FDA rejects Alkermes antidepressant drug ALKS 5461

The Food and Drug Administration turned down a drug for depression that had previously received a negative opinion from a panel of experts the...

Scientists make breakthrough by turning stem cells into insulin-producing cells

US researchers have for the first time transformed human stem cells into cells that produce insulin, marking a significant breakthrough in type...

6 Steps Parents Can Take to Keep Kids’ Hearts Healthy

Heart health is important for adults AND kids alike. The habits that we establish as young...

Garmin’s plan to take on Apple, Fitbit and others in the...

Garmin, the 30-year old public company known for its innovation in GPS navigation systems, is making a major play in the wearable market dominated by...

FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza...

BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone...

Pinpointing patterns in opioid abuse and using data to fight fraud

As the opioid crisis continues to worsen, claiming the lives of more than 130 people each day in the U.S., the healthcare industry needs...

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine January 27, 2019 -- Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC...
0FansLike
65,684FollowersFollow
23,123SubscribersSubscribe

EDITOR PICKS